Evidence map›Paper›PMID 36219612›Full record

ArticleExpert opinion on drug safety2022

Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention.

Djordje S Popovic, Theocharis Koufakis, Bojan Kovacevic, Manfredi Rizzo, Nikolaos Papanas

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Expert opinion on drug safety, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Djordje S PopovicClinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre of Vojvodina, Novi Sad, Serbia.
Theocharis KoufakisDivision of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.ORCID 0000-0002-5853-1352
Bojan KovacevicFaculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Manfredi RizzoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), University of Palermo, Palermo, Italy.ORCID 0000-0002-9549-8504
Nikolaos PapanasDiabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupoli, Greece.
Aristotle University of Thessaloniki · GRDemocritus University of Thrace · GRUniversity of Kragujevac · RSUniversity of Novi Sad · RSUniversity of Palermo · IT

Funding

Versus Arthritis 21605
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, ImmunologicalDiabetes MellitusAttentionHumansImmune Checkpoint InhibitorsImmunotherapyNivolumabAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsNivolumabImmune checkpointsnew-onset DMsafetytherapy

Identifiers

PMID36219612
OpenAlexW4304204842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.